For healthcare professionals, life science professionals, and decision makers

About Us Editorial Team Contact Us

© 2025 - 2026

The Life Science Feed. All rights reserved.

A digital publication from Grá & Mawi Media Co.

Cardiology
Critical Care
Dentistry
Dermatology
Endocrinology
Gastroenterology
General Practice
Genetics
Geriatrics
Haematology

View all therapy areas →

•

Acne Vulgaris
Acute Kidney Injury
Acute Respiratory Distress Syndrome
ADHD
Adrenal Gland Diseases
Alzheimer Disease
Amyotrophic Lateral Sclerosis
Anxiety Disorders
Aortic Valve Stenosis
Aplastic Anemia

View all disease areas →

•

Case
Guidelines
Innovation
Insights
News
Policy
Practice
Research

Disease Area

pulmonary hypertension

Loading articles...

Evidence-based clinical insights for healthcare professionals.

About Us

About
Advertise With Us
AI Disclaimer
Contact Us
Editorial Policy
Editorial Team

Legal

Accessibility
Cookie Policy
Copyright
Privacy Policy
Terms & Conditions

Therapy Areas

Cardiology
Dermatology
Endocrinology
Gastroenterology
Neurology
Oncology
Psychiatry
Pulmonology
Rare Diseases
Rheumatology

View all therapy areas →

© 2025–2026 The Life Science Feed. All rights reserved. A digital publication from Grá & Mawi Media Co.

?

?

0:00 / 0:00

CategoryKeyword

Pulmonary Hypertension
ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
ATS 2026 highlights advancements in nontuberculous mycobacteria (NTM) lung disease, focusing on improved detection, optimized therapy, and patient quality of life.
8 min readRead more
Pulmonary HypertensionATS 2026
YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
YUTREPIA® (treprostinil) inhalation powder offers a new prostacyclin treatment option for pulmonary hypertension associated with interstitial lung disease (PH-ILD).
8 min readRead more
Pulmonary HypertensionATS 2026
IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
An adaptive clinical study programme for IKT-001 in Pulmonary Arterial Hypertension (PAH) was presented at ATS 2026, detailing a novel approach to trial design.
7 min readRead more